US · Healthcare

Rennova Health Inc (RNVA)

Diagnostics & Research

Rennova Health Inc (RNVA) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RNVA

P/E ratio

18.00

Rennova Health Inc (RNVA) — FAQ

What is RNVA's P/E ratio?

The price-to-earnings (P/E) ratio for Rennova Health Inc (RNVA) is 18.00 (data as of 2026-05-23).

Does Rennova Health Inc pay a dividend?

Dividend yield is not available in the current snapshot for Rennova Health Inc (RNVA). Check the MyAverix Finance app for the latest dividend data.

What sector is Rennova Health Inc in?

Rennova Health Inc (RNVA) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is RNVA listed on?

RNVA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)